Maxidex and Visual acuity reduced - a phase IV clinical study of FDA data

Summary:

Visual acuity reduced is reported as a side effect among people who take Maxidex (dexamethasone), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Vancomycin, and have Uveitis.

The phase IV clinical study analyzes which people have Visual acuity reduced when taking Maxidex. It is created by eHealthMe based on reports of 1,297 people who have side effects when taking Maxidex from the FDA, and is updated regularly.

What is Maxidex?

Maxidex has active ingredients of dexamethasone. It is often used in high blood pressure. eHealthMe is studying from 1,348 Maxidex users. Check the latest studies of Maxidex.

What is Visual acuity reduced?

Visual acuity reduced (reduced clearness of vision) is found to be associated with 1,491 drugs and 1,887 conditions by eHealthMe. Check the latest studies of Visual acuity reduced.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

1,297 people reported to have side effects when taking Maxidex.
Among them, 129 people (9.95%) have Visual acuity reduced.

Could Maxidex cause Visual acuity reduced?

Among these 129 people:

How long have people been on Maxidex when they have Visual acuity reduced? *

Click here to view more results

What is the gender of people who have Visual acuity reduced when taking Maxidex? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Maxidex and have Visual acuity reduced?

- Check whether Visual acuity reduced is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Maxidex:

Maxidex (1,348 reports)

Visual acuity reduced treatments and more:

Visual acuity reduced (45,479 reports)

How severe was Visual acuity reduced and when was it recovered:

Visual acuity reduced in Maxidex

Expand to all the drugs that have ingredients of dexamethasone:

Visual acuity reduced and drugs with ingredients of dexamethasone (871 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Maxidex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual acuity reduced:

Visual acuity reduced (1,491 drugs)

Browse all the conditions that are associated with Visual acuity reduced:

Visual acuity reduced (1,887 conditions)

Related publications that referenced our studies

Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .
Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone (the active ingredients of Maxidex) and Maxidex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.